Erectile Dysfunction Holmium Humans *Laser Therapy Lasers Solid-State Length of Stay Male Prostatectomy Prostatic Hyperplasia Quality of Life *Transurethral Resection of Prostate Urethral Stricture Urinary Bladder Urinary Incontinence Urinary Retention benign prostatic hyperplasia bipolar transurethral plasmakinetic prostatectomy transurethral holmium laser enucleation of the prostate

*Arteries Embolization Therapeutic Humans Lower Urinary Tract Symptoms/etiology Male Prostate/*blood supply Prostatic Hyperplasia/complications/diagnosis/*therapy Quality of Life Risk Factors Time Factors Treatment Outcome

Aged Humans Male Middle Aged Prostatic Hyperplasia/blood Prostatic Neoplasms/*blood Publication Bias Sensitivity and Specificity Zinc/*blood

Humans Laser Therapy Male Prostate/radiation effects Prostatic Hyperplasia *Randomized Controlled Trials as Topic Transurethral Resection of Prostate Volatilization Benign prostate hyperplasia (BPH) Meta-analysis Photoselective vaporization of the prostate (PVP) Transurethral resection of the prostate (TURP)

Aged Blood Transfusion/statistics & numerical data Catheters Indwelling/statistics & numerical data Humans Laser Therapy Male Middle Aged Prospective Studies Prostatic Hyperplasia Randomized Controlled Trials as Topic Transurethral Resection of Prostate Treatment Outcome benign prostatic hyperplasia (BPH) prostate transurethral vaporesection transurethral resection of prostate (TURP)

Embolization Therapeutic Humans Lower Urinary Tract Symptoms/*therapy Male Prostate/*blood supply Prostatic Hyperplasia/physiopathology/*therapy benign prostatic hyperplasia lower urinary tract symptoms meta-analysis prostate artery embolization

Disease Progression Humans Kallikreins/blood Male Metabolic Syndrome Organ Size Prostate/growth & development/pathology/physiopathology Prostate-Specific Antigen/blood Prostatic Hyperplasia/pathology/physiopathology

*Arteries/diagnostic imaging Embolization Therapeutic Humans Kallikreins/blood Male Prostate/*blood supply Prostate-Specific Antigen/blood Prostatic Hyperplasia/diagnostic imaging/*therapy Quality of Life Time Factors Treatment Outcome

Adrenergic alpha-1 Receptor Antagonists/*administration & dosage Adrenergic alpha-Antagonists Dose-Response Relationship Drug Humans Male Middle Aged Prostatic Hyperplasia *Quality of Life Sulfonamides/*administration & dosage Tamsulosin Prostatic hyperplasia alpha blockers

Botulinum Toxins Type A/administration & dosage Humans Injections Male Neuromuscular Agents/administration & dosage Prostatic Hyperplasia/*drug therapy Treatment Outcome Benign prostatic hyperplasia Botulinum toxin Meta-analysis Placebo

Humans Female *Urinary Bladder Neoplasms/pathology *Carcinoma Transitional Cell/pathology Urinary Bladder/pathology Prognosis Proportional Hazards Models Meta-analysis Muscle-invasive bladder urothelial carcinoma Non-muscle-invasive bladder urothelial carcinoma Sex

Male Humans *Stomach Neoplasms/genetics *Urinary Bladder Neoplasms/genetics Urinary Bladder Membrane Proteins RNA Messenger Antigens Neoplasm/genetics Neoplasm Proteins GPI-Linked Proteins/genetics Psca cancer risk polymorphism rs2294008 (C/T)

Male Humans *Papillomavirus Infections/complications/epidemiology/prevention & control Human Papillomavirus Viruses Mendelian Randomization Analysis Papillomaviridae/genetics Human papillomavirus 18 *Urinary Bladder Neoplasms/epidemiology/complications HPV prevalence bladder cancer human papillomavirus mendelian randomization meta-analysis

Humans Female *Carcinoma Transitional Cell/chemically induced/epidemiology/genetics DNA Adducts/adverse effects *Drugs Chinese Herbal/adverse effects Taiwan/epidemiology *Urinary Bladder Neoplasms Carcinogens *Kidney Neoplasms/chemically induced/epidemiology/genetics *Aristolochic Acids/adverse effects/analysis *Ureteral Neoplasms/chemically induced/epidemiology *Urinary Tract Aristolochia DNA adduct Mass spectrometry Nephropathy Renal pelvic cancer Ureteral cancer

Cohort Studies *Dietary Fats/adverse effects Female Humans Male Prospective Studies Risk Factors Sugars *Urinary Bladder Neoplasms/epidemiology/etiology bladder cancer diet epidemiology fat oil risk factor

Cohort Studies Female Humans Male Prospective Studies Risk Factors Tea *Urinary Bladder Neoplasms/epidemiology/etiology Dose–response analysis Epidemiology Smoking Urinary bladder cancer

Biomarkers/urine Carcinogenesis Carcinogens/toxicity Female Humans Male *Tobacco Products/adverse effects *Urinary Bladder Neoplasms/etiology Biomarkers of exposure Bladder cancer Carcinogens Heated tobacco product Urine disclosures.

Aged Antineoplastic Combined Chemotherapy Protocols/*therapeutic use Carcinoma Transitional Cell/*drug therapy/*pathology Female Humans Immune Checkpoint Inhibitors/*therapeutic use Liver Neoplasms/secondary Male Middle Aged Survival Analysis Urinary Bladder Neoplasms/*drug therapy/*pathology bladder cancer immune checkpoint inhibitors immunotherapy meta-analysis urothelial carcinoma

Case-Control Studies Female Humans Male *Menarche Odds Ratio Risk Factors *Urinary Bladder Neoplasms/epidemiology/etiology Bladder cancer Menarche Meta-analysis

Female Humans Male Research Design/*standards Urinary Bladder Neoplasms/*diagnosis/*diagnostic imaging Bladder cancer Magnetic resonance imaging Meta-analysis Vesical Imaging Reporting and Data System